icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Back to Basics: Laurel Alterman and William A. Gibson v. Commissioner of Internal Revenue

By Greg Pelucacci, CohnReznick senior associate In the rapidly growing industry of cannabis, there are several important concepts for owners to understand. One of the most popular topics would be Internal Revenue Code (IRC) Section (§) 280E: Passed in 1982, that code section prohibits companies that traffic Controlled Substances Act (CSA) Schedule I or II […]
Read more

“The Black Experience in Cannabis” Event hosted by the Congressional Black Caucus Foundation

Interview with Kia L. Jackson, CEO of W.O.M.M.A.N, LLC, by Michael Harlow, Tax Partner, CohnReznick Over the past two decades, cannabis legalization has remained a divisive topic. This fall, the Congressional Black Caucus Foundation’s 48th Annual Legislative Conference (ALC) presented “The Black Experience in Cannabis”, highlighting people of color’s narrative in cannabis with panels [...]
Read more

Illinois Legalizes Industrial Hemp

  By Larry Mishkin, Hoban Law Group, Litigation Practice Group Counsel Last month, Illinois Gov. Bruce Rauner signed into law Senate Bill 2298, the Illinois Industrial Hemp Act, which became effective immediately. The act allows Illinois farmers, in conjunction with a university or other recognized research group, to cultivate industrial hemp for research and commercial […]
Read more

Cannabis Research Efforts Progressing Despite Federal Tax and Banking Regulations

By Michael Harlow and Craig Golding Partners at CohnReznick There are some unique challenges to conducting research in the United States on the medical applications of cannabis. Cannabis’ federal Schedule I classification presents several obstacles for cannabis industry operators and businesses, even for those located in states where medical and recreational use is legal. Strict [...]
Read more

Federal Restrictions on Cannabis Still a Hurdle to Understanding the Plant’s Genome – But There is Good News

By Tracy Curley, Partner at Cohnreznick The legal status of cannabis presents a challenge toward advancements in quality assurance and medical research. Currently, the Controlled Substance Act carries no distinction between the medical and recreational uses of cannabis, which is classified as a Schedule I drug – meaning a substance or chemical defined by the […]
Read more

States Challenged to Optimize Cannabis Tax Revenues

Some reinventing the cannabis tax-reform wheel as they go along By Bob Moss, Principal, National Director of Governmental Affairs & Eddie Delgado, CMI, Cohn Reznick For the states with cannabis initiatives on the ballot this fall, there is a fine line between passing legislation and being prepared to implement the new law. With time and more […]
Read more

The Tax Cuts and Jobs Act: Key Considerations for Cannabis Businesses

By Mary Amato, CPA, Partner The Tax Cuts and Jobs Act (“the Act”), signed by President Trump on December 22, 2017, is the most sweeping update to the tax code since 1986. While technical corrections and interpretive guidance issued by the IRS are forthcoming, taxpayers must understand which provisions will affect them and how. Cannabis […]
Read more
Top